Overview
Hidemasa Oh practices in Okayama, Japan. Oh is rated as an Elite expert by MediFind in the treatment of Hypoplastic Left Heart Syndrome (HLHS). Their top areas of expertise are Hypoplastic Left Heart Syndrome (HLHS), Congenital Heart Disease (CHD), Dilated Cardiomyopathy (DCM), and Heart Failure.
Their clinical research consists of co-authoring 11 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles and participated in 1 clinical trial in the study of Hypoplastic Left Heart Syndrome (HLHS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Hypoplastic Left Heart Syndrome (HLHS)
- Advanced
- Congenital Heart Disease (CHD)
- Experienced
- CardiomyopathyOh isExperienced. Learn about Cardiomyopathy.
- Congenital Coronary Artery Malformation
- Dilated Cardiomyopathy (DCM)
- Heart FailureOh isExperienced. Learn about Heart Failure.
- Heart Failure with Preserved Ejection Fraction (HFpEF)